BrainsWay Ltd (BWAY)
5.40
-0.02
(-0.37%)
USD |
NASDAQ |
May 16, 16:00
5.42
+0.02
(+0.37%)
After-Hours: 20:00
BrainsWay Price to Book Value: 2.141 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.141 |
| May 15, 2024 | 2.149 |
| May 14, 2024 | 2.173 |
| May 13, 2024 | 2.180 |
| May 10, 2024 | 2.113 |
| May 09, 2024 | 2.161 |
| May 08, 2024 | 2.260 |
| May 07, 2024 | 2.414 |
| May 06, 2024 | 2.284 |
| May 03, 2024 | 2.292 |
| May 02, 2024 | 2.307 |
| May 01, 2024 | 2.203 |
| April 30, 2024 | 2.080 |
| April 29, 2024 | 2.000 |
| April 26, 2024 | 1.886 |
| April 25, 2024 | 1.902 |
| April 24, 2024 | 1.993 |
| April 23, 2024 | 1.955 |
| April 22, 2024 | 1.882 |
| April 19, 2024 | 1.929 |
| April 18, 2024 | 1.898 |
| April 17, 2024 | 2.000 |
| April 16, 2024 | 2.024 |
| April 15, 2024 | 2.088 |
| April 12, 2024 | 2.040 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.100 |
| April 10, 2024 | 2.139 |
| April 09, 2024 | 2.076 |
| April 08, 2024 | 2.084 |
| April 05, 2024 | 2.119 |
| April 04, 2024 | 2.123 |
| April 03, 2024 | 2.226 |
| April 02, 2024 | 2.119 |
| April 01, 2024 | 2.183 |
| March 31, 2024 | |
| March 28, 2024 | 2.117 |
| March 27, 2024 | 2.101 |
| March 26, 2024 | 2.181 |
| March 25, 2024 | 2.173 |
| March 22, 2024 | 2.325 |
| March 21, 2024 | 2.377 |
| March 20, 2024 | 2.361 |
| March 19, 2024 | 2.401 |
| March 18, 2024 | 2.425 |
| March 15, 2024 | 2.325 |
| March 14, 2024 | 2.269 |
| March 13, 2024 | 2.433 |
| March 12, 2024 | 2.501 |
| March 11, 2024 | 2.501 |
| March 08, 2024 | 2.377 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5627
Minimum
May 10 2023
22.38
Maximum
May 17 2019
3.047
Average
2.394
Median
Feb 17 2022
Price to Book Value Benchmarks
| Compugen Ltd | 2.922 |
| Pluri Inc | -- |
| BioLine Rx Ltd | 3.881 |
| Can Fite Biofarma Ltd | 1.788 |
| BiomX Inc | 5.916 |
Price to Book Value Related Metrics
| PS Ratio | 2.612 |
| Price to Free Cash Flow | 18.29 |
| Price | 5.40 |
| Earnings Yield | -1.96% |
| Market Cap | 89.92M |